IRIS
PAPI, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25249
EU - Europa 5974
AS - Asia 3370
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 15
SA - Sud America 11
AF - Africa 7
Totale 34646
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25231
CN - Cina 2168
UA - Ucraina 1747
IT - Italia 1018
TR - Turchia 993
DE - Germania 860
GB - Regno Unito 624
NL - Olanda 484
SE - Svezia 472
FI - Finlandia 386
PL - Polonia 149
FR - Francia 108
VN - Vietnam 92
BE - Belgio 38
IN - India 32
TW - Taiwan 18
AU - Australia 17
JP - Giappone 15
AT - Austria 14
CA - Canada 14
EU - Europa 13
RU - Federazione Russa 13
ES - Italia 11
IR - Iran 10
HK - Hong Kong 9
IE - Irlanda 9
KR - Corea 9
RO - Romania 9
CH - Svizzera 8
PT - Portogallo 8
EG - Egitto 5
TH - Thailandia 5
BR - Brasile 4
GR - Grecia 4
MX - Messico 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
CL - Cile 2
HR - Croazia 2
ID - Indonesia 2
IL - Israele 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
AR - Argentina 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
HN - Honduras 1
HU - Ungheria 1
KE - Kenya 1
LK - Sri Lanka 1
MA - Marocco 1
NO - Norvegia 1
PH - Filippine 1
SA - Arabia Saudita 1
SG - Singapore 1
UZ - Uzbekistan 1
Totale 34646
Salva come PNG Salva come JPEG
Città #
Fairfield 4047
Woodbridge 3629
Houston 2610
Jacksonville 2032
Ashburn 1634
Chandler 1631
Seattle 1488
Wilmington 1427
Ann Arbor 1326
Cambridge 1316
Izmir 696
Nanjing 628
Princeton 564
San Diego 364
Beijing 302
Ferrara 284
Boardman 279
Washington 217
Nanchang 192
Shenyang 165
Milan 154
Warsaw 146
Addison 131
Hebei 124
Tianjin 124
Dearborn 108
Changsha 101
Jiaxing 100
Dong Ket 90
Mountain View 86
Falls Church 79
Redwood City 74
London 67
Norwalk 66
Zhengzhou 56
Kunming 50
Bremen 49
Jinan 49
Ningbo 45
Orange 45
Guangzhou 39
Chicago 38
Brussels 37
San Mateo 36
Auburn Hills 31
Taizhou 31
Verona 29
Lanzhou 27
Des Moines 26
Philadelphia 24
Helsinki 23
Los Angeles 20
Paris 20
Changchun 19
Hangzhou 19
Rome 18
Shanghai 18
Indiana 15
Redmond 15
Augusta 14
Munich 14
Bologna 13
Hefei 13
Napoli 11
Pordenone 11
New York 10
Oristano 10
Vienna 10
Taipei 9
Walnut 9
Catania 8
Florence 8
Leawood 8
Wuhan 8
Ferrara di Monte Baldo 7
Fuzhou 7
Monmouth Junction 7
Padova 7
Haikou 6
San Francisco 6
Taiyuan 6
Torino 6
Yokohama 6
Dallas 5
New Delhi 5
Toronto 5
Ardabil 4
Delebio 4
Dublin 4
Duncan 4
Lecco 4
Mumbai 4
Reggio Nell'emilia 4
Shaoxing 4
Tokyo 4
Yellow Springs 4
Aci Catena 3
Amadora 3
Aversa 3
Bergamo 3
Totale 27341
Salva come PNG Salva come JPEG
Nome #
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program 555
Value of fiberoptic bronchoscopy in addition to 18F-FDG-PET/CT in the differentiation of solitary pulmonary nodules: a prospective study 282
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 254
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD 157
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 157
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial 156
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 142
Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthma 140
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 136
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 134
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial 132
Oxygen radical scavengers inhibit clastogenic activity induced by sonication of human serum 131
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 131
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 129
COPD: early diagnosis and treatment to slow disease progression 128
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 126
Malattie polmonari primitive da cause dismetaboliche. 126
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 125
Models of infection and exacerbations in COPD. 124
INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD. 124
Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: A pooled analysis. 124
Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations 124
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 124
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial 122
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 122
null 121
Rhinovirus vaccination: the case against 118
null 118
Effect of subchronic in vivo exposure to nitrogen dioxide on lung tissue inflammation, airway microvascular leakage, and in vitro bronchial muscle responsiveness in rats 117
null 117
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial 117
Cost-effectiveness and cost-utility of beclomethasone/formoterol versus fluticasone propionate/salmeterol in patients with moderate to severe asthma. 116
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 116
Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS. 116
Management of bronchial asthma 114
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 114
null 114
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease 114
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 113
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 112
null 111
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 111
Primary pulmonary epithelioid hemangioendothelioma: A rare cause of PET-negative pulmonary nodules 111
Extrafine beclometasone diproprionate/formoterol fumarate: A review of its effects in chronic obstructive pulmonary disease 110
Combination treatment in asthma: Reviewing old and new options 109
Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation 108
Mechanisms of rhinovirus-induced asthma. 108
Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma. 108
Slower rise of exhaled breath temperature, in chronic obstructive pulmonary disease 107
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. 107
Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma 105
Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis 104
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 104
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 104
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. 103
Reducing agents inhibit rhinovirus-induced up-regulation of the rhinovirus receptor intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells 103
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 103
Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial 103
Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patients. 103
null 102
Oxidants in asthma and in chronic obstructive pulmonary disease (COPD) 101
COPD exacerbations: definitions and classifications 101
B Cell Activating Factor (BAFF) Is Expressed by Lymphoid Follicles of COPD Patients 101
Unbalanced oxidant-induced DNA damage and repair in COPD: A link towards lung cancer 101
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 101
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. 100
Extrafine beclomethasone dipropionate/formoterol hydrofluoroalkane-propelled inhaler in asthma. 100
Management of patients with early mild asthma and infrequent symptoms 100
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium 100
The future of relievers and controllers in asthma therapy. 100
Emphysema contribution to the progression of chronic obstructive pulmonary disease. 99
Clinical definition of COPD exacerbations and classification of their severity 99
Recent thymic emigrants do not account for the increased number of T-cells seen in the lungs of stable chronic obstructive pulmonary disease 99
Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD. 99
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline 99
PROTECTION OF ERDOSTEINE ON SMOKE-INDUCED PERIPHERAL NEUTROPHIL DYSFUNCTION BOTH IN HEALTHY AND IN BRONCHITIC SMOKERS 98
Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells. 98
Mechanisms involved in lung cancer development in COPD 98
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma. 98
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 98
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 98
Bronchopulmonary inflammation and airway smooth muscle hyperresponsiveness induced by nitrogen dioxide in guinea pigs 98
IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease 97
Short term efficacy of nebulized beclomethasone in mild-to-moderate wheezing episodes in pre-school children 97
Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial. 97
Near-fatal asthma phenotype in the ENFUMOSA Cohort. 96
Reducing Agents Decrease the Oxidative Burst and Improve Clinical Outcomes in COPD Patients: A Randomised Controlled Trial on the Effects of Sulphurous Thermal Water Inhalation. 96
Steroid-sparing Strategies: Other Combinations 95
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics 95
A valid option for asthma control: Clinical evidence on efficacy and safety of fluticasone propionate/formoterol combination in a single inhaler 95
IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma 95
Dual Bronchodilation Response by Exacerbation History and Eosinophilia in the FLAME Study 95
Inhaled beclometasone dipropionate/formoterol extra-fine fixed combination in the treatment of asthma: evidence and future perspectives. 95
Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease 95
Molecular mechanisms of respiratory virus-induced asthma and COPD exacerbations and pneumonia. 94
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 94
null 94
Small airway disease in asthma: pathophysiological and diagnostic considerations 94
Increased activation of p38 MAPK in COPD. 94
Molecular mechanisms of respiratory virus-induced inflammation. 94
Totale 11764
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72631
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3760
Totale 76391
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018425 0000 00 00 1282223441
2018/20195340 132153138 3266 60138 42489710831974
2019/20209055 13842813561346 6661283 806959 737752289196
2020/20216478 437479305731 321681 279751 170784881659
2021/20225146 219452320258 197236 283293 2043804611843
2022/20233681 575103145491 619645 194402 507000
Totale 35517